Pfizer Inc. said on Friday that it has pulled out an application for emergency use authorization of the BioNTech-Pfizer coronavirus vaccine in India. The decision came after Pfizer representatives met with Indias health regulator on Wednesday, who refused to grant the pharmaceuticals vaccine the authorization, citing a lack of immunogenicity trials.Based